Table 1.
drug conc. | Time window 1: 24–48 hpf |
Time window 2: 20–48 hpf |
Time window 3: 12/16–24 hpf |
Time window 4: 30–48 hpf |
||||
---|---|---|---|---|---|---|---|---|
stages | phenotypes | stages | phenotypes | stages | phenotypes | stages | phenotypes | |
LY-411575 1 µM |
48 hpf | follicle cells markers expression decreased; neurogenesis markers expression maintained | 48 hpf | overexpression of chaetoblast marker; presence of abortive chaetoblasts | 24 hpf | Elav expression in maintained in 9 neurons | 72 hpf | normal number of brain cells/ number of VNC neurons slightly enhanced |
72 hpf | absence of chaetae/normal chaetoblasts; normal VNC |
72 hpf | absence of chaetae; development slightly delayed |
72 hpf | absence of chaetae | |||
6 dpf | absence of chaetae/normal VNC | |||||||
RO-4929097 2 µM |
48 hpf | follicle cells markers expression decreased; neurogenesis markers expression maintained | 48 hpf | absence of chaetae/very few abortive chaetoblasts | ||||
72 hpf | absence of chaetae/normal chaetoblasts; normal VNC |
72 hpf | absence of chaetae | |||||
6 dpf | absence of chaetae/normal VNC | |||||||
RO-4929097 30 µM |
48 hpf | absence of chaetae/development delayed | 48 hpf | abnormal expression of chaetoblast marker; presence of abortive supernumerary chaetoblasts | 24 hpf | Elav expression is maintained in 9 neurons | 72 hpf | normal number of brain cells; development delayed |
72 hpf | absence of chaetae/development delayed | 72 hpf | absence of chaetae; development delayed |
72 hpf | absence of chaetae; development delayed | |||
later | dead | |||||||
DAPT 40 µM |
48 hpf | follicle cells markers expression decreased; neurogenesis markers expression maintained | ||||||
72 hpf | absence of chaetae/normal chaetoblasts; normal VNC | |||||||
6 dpf | absence of chaetae/normal VNC |